Matthew Gall, CFO of Tango Therapeutics TNGX, has filed 2 purchases and 0 sales on the open market. The latest trade was on 05/01.

MG

MG

Matthew Gall

CFO

Company

Tango Therapeutics TNGX

First filing

23/03/10

Trades

17 trades

Buys / sales

2 / 0

12-month net buying

No record

Last trade

05/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
IT iTeos Therapeutics	Open-market buy	24/11/19	24/11/19	5,000 sh	$7.73	$38,650	+8.3%
IT iTeos Therapeutics	Open-market buy	23/10/12	23/10/12	5,000 sh	$8.37	$41,850	+34.7%